LEADER 02840nam  22004815  450 
001 9910300274603321
005 20200702212910.0
010   $a3-319-71846-0
024 7 $a10.1007/978-3-319-71846-0
035   $a(CKB)4100000002892159
035   $a(MiAaPQ)EBC5439838
035   $a(DE-He213)978-3-319-71846-0
035   $a(PPN)225552388
035   $a(EXLCZ)994100000002892159
100   $a20180327d2018      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPET/CT in Thyroid Cancer /$fedited by Sobhan Vinjamuri
205   $a1st ed. 2018.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018.
215   $a1 online resource (93 pages)
225 1 $aPET/CT,$x2367-2439 
311   $a3-319-71845-2 
327   $aIntroduction to Thyroid Cancer -- Pathology of Thyroid cancer -- Management of Thyroid Cancer -- Radiological Imaging in Thyroid Cancer -- Radionuclide Imaging in Thyroid Cancer -- FDG PET-CT in Thyroid Cancer -- Normal Variants , Artefacts and Pitfalls -- Pictorial Atlas.
330   $aThis pocket book provides a comprehensive review of the current use of PET/CT in thyroid cancer, offering a multidisciplinary perspective and explaining the role of PET/CT in relation to other imaging modalities. A key aim is to help readers to choose the correct imaging modality to answer the clinical question at hand, thereby assisting in patient management. Highlights of the book include the exquisite depiction of normal variants, pitfalls, and artifacts and a pictorial atlas of the types of thyroid cancer and their imaging appearances. Readers will also find helpful information on the relation of the clinical and pathological background to imaging. The book will be an excellent asset for practitioners and trainees in Nuclear Medicine and members of endocrine and oncology teams. It is published within the Springer series Clinicians? Guides to Radionuclide Hybrid Imaging, in which leading professionals succinctly explain the importance of nuclear medicine in the diagnosis and management of oncological and non-oncological conditions.
410  0$aPET/CT,$x2367-2439 
606   $aNuclear medicine
606   $aOncology  
606   $aNuclear Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H29048
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
615  0$aNuclear medicine.
615  0$aOncology  .
615 14$aNuclear Medicine.
615 24$aOncology.
676   $a616.99444
702   $aVinjamuri$b Sobhan$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910300274603321
996   $aPET$92588800
997   $aUNINA